BRIEF published on 11/06/2024 at 07:35, 1 year ago HENSOLDT Reports Significant Revenue Growth in Q3 2024 Revenue Growth Order Intake EBITDA Improvement Defense Contracts ESG Integration
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year ago HENSOLDT reports revenue growth and significantly higher order intake in third quarter of 2024 HENSOLDT reports revenue growth and significantly higher order intake in the third quarter of 2024, showcasing positive business performance and operational excellence Revenue Growth Order Intake HENSOLDT 2024 Financial Year Defence Solutions
BRIEF published on 07/26/2024 at 07:35, 1 year 4 months ago HENSOLDT Announces Strong Financial Performance in First Half of 2024 Revenue Growth Profitability Order Intake HENSOLDT Defense Electronics
PRESS RELEASE published on 07/26/2024 at 07:30, 1 year 4 months ago HENSOLDT with strong order intake and increased profitability in the first half of 2024 HENSOLDT reports strong order intake and increased profitability in the first half of 2024. Revenue up 17.0% to EUR 849 million. Adjusted EBITDA rises by 26.2% to EUR 103 million EBITDA Revenue Profitability Order Intake HENSOLDT
BRIEF published on 07/10/2024 at 18:19, 1 year 4 months ago Celia Pelaz Resigns from HENSOLDT AG Management Board Resignation Supervisory Board Management Board HENSOLDT Celia Pelaz
PRESS RELEASE published on 07/10/2024 at 18:14, 1 year 4 months ago Celia Pelaz resigns from the Management Board of HENSOLDT AG Celia Pelaz resigns from the Management Board of HENSOLDT AG by mutual consent. Supervisory Board praises her significant contributions. Operational excellence remains top priority for Management Board Operational Excellence Resignation Supervisory Board Management Board HENSOLDT AG
BRIEF published on 05/07/2024 at 07:35, 1 year 6 months ago HENSOLDT Reports Strong First Quarter in 2024 with Surge in Order Intake Revenue Growth Earnings Report Order Intake HENSOLDT Defense Industry
PRESS RELEASE published on 05/07/2024 at 07:30, 1 year 6 months ago HENSOLDT continues positive business development in the first quarter of 2024 and benefits from strong order intake HENSOLDT reports positive business development in Q1 2024 with 91.8% order intake growth to EUR 665 million and record high order backlog of EUR 5,879 million Acquisition Financial Results Business Development Order Intake HENSOLDT
BRIEF published on 04/03/2024 at 07:35, 1 year 8 months ago HENSOLDT Acquires ESG, Bolstering Its Defence Electronics and System Integration Capabilities Acquisition ESG HENSOLDT Defence Electronics System Integration
PRESS RELEASE published on 04/03/2024 at 07:30, 1 year 8 months ago HENSOLDT completes acquisition of ESG HENSOLDT completes acquisition of ESG, creating a national champion in defence electronics. Acquisition adds strong design and system integration capabilities to HENSOLDT's business Acquisition ESG HENSOLDT Defence Electronics System Integrator
Published on 12/05/2025 at 02:35, 3 hours 53 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 28 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 23 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 28 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 13 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 17 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 28 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 44 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 27 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
